Erice Manifesto 2022: On the Surveillance of Potential Harms Caused by Food Supplements in Europe Francesca Menniti-IppolitoEugenio AielloGwenn Vo Van Regnault Editorial 06 April 2023 Pages: 435 - 437
Implications of Non-Specific Effects for Testing, Approving, and Regulating Vaccines Christine Stabell BennNelly AmenyogbePeter Aaby Current Opinion Open access 19 April 2023 Pages: 439 - 448
Drug–Drug Interactions and the Risk of Emergency Hospitalizations: A Nationwide Population-Based Study Louis LétinierJulien BezinAntoine Pariente Original Research Article 12 April 2023 Pages: 449 - 456
Validation of an ICD-9-Based Algorithm to Identify Stillbirth Episodes from Medicaid Claims Data Sabina O. NduagubaNicole E. SmolinskiAlmut G. Winterstein Original Research Article 12 April 2023 Pages: 457 - 465
Maternal and Early-Life Exposure to Antibiotics and the Risk of Autism and Attention-Deficit Hyperactivity Disorder in Childhood: a Swedish Population-Based Cohort Study Lembris L. NjottoJohanna SiminNele Brusselaers Original Research Article Open access 23 April 2023 Pages: 467 - 478
Core Data Elements for Pregnancy Pharmacovigilance Studies Using Primary Source Data Collection Methods: Recommendations from the IMI ConcePTION Project Jonathan L. RichardsonAlan MooreLaura M. Yates Original Research Article Open access 28 March 2023 Pages: 479 - 491
Prevalence and Preventability of Adverse Medicine Events in a Sample of Australian Aged-Care Residents: A Secondary Analysis of Data from the ReMInDAR Trial Lisa M. Kalisch EllettGerel DorjElizabeth E. Roughead Original Research Article Open access 19 April 2023 Pages: 493 - 500
Quality of MedDRA® Coding in a Sample of COVID-19 Vaccine Medication Error Data Katarina KralovaCarol-Ann WilsonJoan D’souza Original Research Article 23 April 2023 Pages: 501 - 507
Comment on "Drug–Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data" Oliver KussWolfgang Rathmann Letter to the Editor Open access 15 April 2023 Pages: 509 - 512
Author’s Reply to Kuss and Rathmann’s Comment on: “Drug-Drug Interaction of the Sodium Glucose Co-transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data” John-Michael GambleWajd Alkabbani Letter to the Editor 15 April 2023 Pages: 513 - 514
Correction to: Development and Validation of ICD‑10‑CM‑based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes Andrea K. ChomistekKelesitse PhiriJohn D. Seeger Correction Open access 24 March 2023 Pages: 515 - 515